Filtered By:
Cancer: Lung Cancer

This page shows you your search results in order of date. This is page number 15.

Order by Relevance | Date

Total 532 results found since Jan 2013.

Effects of Smoking on Long-Term Clinical Outcomes and Lung Cancer in Patients with Acute Myocardial Infarction
CONCLUSIONS: In contrast to the unadjusted model, smoking is associated with worse cardiovascular outcome and higher incidence of lung cancer after adjustment of various confounding factors. This result can be explained by the characteristics of smokers, which were young and had fewer comorbidities.PMID:33821583 | PMC:PMC8022024 | DOI:10.4070/kcj.2020.0430
Source: Korean Circulation Journal - April 6, 2021 Category: Cardiology Authors: Su Nam Lee Ik Jun Choi Sungmin Lim Eun Ho Choo Byung Hee Hwang Chan Joon Kim Mahn Won Park Jong Min Lee Chul Soo Park Hee Yeol Kim Ki Dong Yoo Doo Soo Jeon Ho Joong Youn Wook Sung Chung Min Chul Kim Myung Ho Jeong Youngkeun Ahn Kiyuk Chang Source Type: research

IJERPH, Vol. 18, Pages 3629: Health Knowledge about Smoking, Role of Doctors, and Self-Perceived Health: A Cross-Sectional Study on Smokers ’ Intentions to Quit
IJERPH, Vol. 18, Pages 3629: Health Knowledge about Smoking, Role of Doctors, and Self-Perceived Health: A Cross-Sectional Study on Smokers’ Intentions to Quit International Journal of Environmental Research and Public Health doi: 10.3390/ijerph18073629 Authors: Tianfeng He Lefan Liu Jing Huang Guoxing Li Xinbiao Guo Limited empirical work has been done to compare the effects that health knowledge and advice from doctors have on smokers’ intentions to quit. This paper examines the association of smokers’ intentions to quit with health knowledge, advice from doctors, and self-perceived health. A sample...
Source: International Journal of Environmental Research and Public Health - March 31, 2021 Category: Environmental Health Authors: Tianfeng He Lefan Liu Jing Huang Guoxing Li Xinbiao Guo Tags: Article Source Type: research

Ambient particulate matter burden of disease in the Kingdom of Saudi Arabia
CONCLUSION: Ambient particulate matter is the fifth health risk factor in Saudi Arabia, contributing 9% of total mortality. Over the past 27 years, estimated exposure levels of PM2.5 in Saudi Arabia have been above WHO's air quality guidelines. Although since 2011 mortality and DALY rates attributable to PM2.5 have decreased, air pollution concentrations continue to increase. National and local authorities in Saudi Arabia should consider policies to reduce industrial and traffic-related air pollution in combination with the strengthening of current investments and improvements in health care and prevention services.PMID:33...
Source: Environmental Research - March 29, 2021 Category: Environmental Health Authors: D Rojas-Rueda W Alsufyani C Herbst S AlBalawi R Alsukait M Alomran Source Type: research

Spatial patterns and temporal variations of traffic-related air pollutants and estimating its health effects in Isfahan city, Iran
AbstractIsfahan as an important industrial city has faced with air pollution recently. Thus, we assessed the spatial and temporal trends of ambient PM2.5, CO, SO2, and O3 and for estimating their health effect on Isfahan citizens between March 2018 and March 2019 through the AirQ+ software. Our results showed that citizens of Isfahan in almost 240, 167, and 134 of the days in the year has exposure to PM2.5, SO2, and O3 higher than the WHO daily guideline, respectively. Daily variations of PM2.5, CO, and SO2 concentration showed the increasing trend of pollutants in the morning to evening. The maximum concentrations of O3 w...
Source: Journal of Environmental Health Science and Engineering - March 18, 2021 Category: Environmental Health Source Type: research

The Economic Burden of Smoking ‑Attribution and Years of Life Lost due to Chronic Diseases in Mashhad, 2015–2016
Conclusions: The results of this study can be used to inform policy ‑makers about smoking‑attributable diseases in Iran. To decrease the smoking‑attributable costs, which have resulted in the spread of NCDs, policy‑makers should adopt and implement effective policies regarding smoking prevention and control.
Source: International Journal of Preventive Medicine - March 17, 2021 Category: International Medicine & Public Health Source Type: research

Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With Cancer
CONCLUSION: In this observational study of an aggregated US patient population, those with newly diagnosed cancer had increased risk of ATE events. This risk was most elevated in a 330-day window around cancer diagnosis and was consistent across different types of ATE and cancer.PMID:33673912 | DOI:10.1016/j.mayocp.2020.05.045
Source: Clinical Colorectal Cancer - March 6, 2021 Category: Cancer & Oncology Authors: Jiasheng Wang Yeseong D Kim Chang H Kim Source Type: research

Secondhand Smoke Exposure Among Nonsmoking Adults: United States, 2015-2018.
This report examines the prevalence of SHS exposure among nonsmoking U.S. adults in 2015-2018 based on blood levels of cotinine, a metabolite of nicotine. Trends in SHS exposure are also presented. PMID: 33541515 [PubMed - in process]
Source: NCHS data brief - February 6, 2021 Category: American Health Tags: NCHS Data Brief Source Type: research

Stroke ambulances improve patient outcomes
Ambulances fitted to function as mobile stroke units -- with CT, point-of-car...Read more on AuntMinnie.comRelated Reading: Canon launches mobile CT to combat COVID-19 Mobile CT improves access to lung cancer screening Stroke care looks skyward with new mobile CT program Mobile CT unit boosts efficiency of stroke triage Ambulance with mobile CT cuts stroke treatment times
Source: AuntMinnie.com Headlines - February 2, 2021 Category: Radiology Source Type: news

Targeted Cancer Therapies.
Abstract Targeted cancer therapies involve chemotherapeutic agents that attack, directly or indirectly, a specific genetic biomarker found in a given cancer. Targeted oncology includes monoclonal antibodies, small molecule inhibitors, antibody-drug conjugates, and immunotherapy. For example, the monoclonal antibodies trastuzumab and pertuzumab target human epidermal growth factor receptor 2 (HER2) and are used when treating HER2-positive breast cancer. Although targeted oncology has improved survival by years for some incurable cancers such as metastatic breast and lung cancer, as few as 8% of patients with advanc...
Source: American Family Physician - January 30, 2021 Category: Primary Care Authors: Smith CEP, Prasad V Tags: Am Fam Physician Source Type: research